Skip to main content

Adaptive Biotechnologies Corp

ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001478320

In the last 90 days, Adaptive Biotechnologies Corp insiders filed 0 open-market purchases and 13 sales; 301 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; superinvestors Viking Global Investors and ARK Invest hold it.

Q2 2025 vs. Q1 2025

How the institutions holding Adaptive Biotechnologies Corp changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of ADPT: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders2253242+20
Shares152.9M81.4K148.2M−4.67M (−3.1%)
Value$1.14B$605.1K$1.73B+$590.6M (+52.0%)

3 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (46)

Institutions that held Adaptive Biotechnologies Corp at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to ADPT in Q2 2025
InstitutionSharesValue% of portfolio
Fred Alger Management, LLC2,355,427$27.4M0.12%
Point72 Asset Management, L.P.1,373,923$16.0M0.04%
Peregrine Capital Management LLC702,711$8.19M0.25%
Macquarie Group Ltd660,056$7.69M0.01%
D. E. Shaw & Co., Inc.608,280$7.09M0.01%
Oberweis Asset Management Inc589,400$6.87M0.30%
Hillsdale Investment Management Inc.568,090$6.62M0.24%
Cubist Systematic Strategies, LLC458,871$5.35M0.06%
EAM Global Investors LLC409,363$4.77M1.24%
Qube Research & Technologies Ltd364,768$4.25M0.01%
EAM Investors, LLC321,573$3.75M0.57%
Zimmer Partners, LP252,900$2.95M0.07%
Moore Capital Management, LP250,000$2.91M0.06%
Susquehanna Portfolio Strategies, LLC218,858$2.55M0.06%
University of Texas/Texas Am Investment Managment Co211,518$2.46M0.39%
Jump Financial, LLC183,843$2.14M0.03%
Panagora Asset Management Inc158,576$1.85M0.01%
Polen Capital Management LLC142,257$1.66M0.01%
Hedeker Wealth, LLC121,667$1.42M0.33%
Aquatic Capital Management LLC108,190$1.26M0.03%
XTX Topco Ltd68,055$792.8K0.03%
Quantbot Technologies LP50,374$586.9K0.02%
Jupiter Asset Management Ltd49,970$582.2K0.00%
Cookson Peirce & Co Inc45,000$524.3K0.02%
Envestnet Asset Management Inc40,094$467.1K0.00%
Toroso Investments, LLC38,025$443.0K0.00%
Diversified Trust Co37,634$438.4K0.01%
Integrated Quantitative Investments LLC36,430$424.4K0.12%
State of Wyoming35,287$411.1K0.05%
Versor Investments LP31,500$367.0K0.06%
Dynamic Technology Lab Private Ltd25,468$296.0K0.04%
Citizens Financial Group Inc14,776$172.1K0.00%
Stifel Financial Corp12,705$148.0K0.00%
Xponance, Inc.11,677$136.0K0.00%
Universal- Beteiligungs- und Servicegesellschaft mbH11,506$134.0K0.00%
Comerica Bank2,024$23.6K0.00%
Caitong International Asset Management Co., Ltd1,106$12.9K0.01%
NBC Securities, Inc.985$11.0K0.00%
Group One Trading, L.P.887$10.3K0.00%
Private Trust Co NA789$9.19K0.00%
Essential Partners LLC574$6.69K0.00%
Assetmark, Inc201$2.34K0.00%
Hughes Financial Services, LLC65$7600.00%
Global Retirement Partners, LLC37$4310.00%
Ronald Blue Trust, Inc.21$2450.00%
Clearstead Advisors, LLC4$470.00%

Sold out (26)

Institutions that held Adaptive Biotechnologies Corp at the end of Q1 2025 and filed for Q2 2025 without it.

Not filed for Q2 2025 yet (3)

Institutions that held Adaptive Biotechnologies Corp at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ADPT in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Rappaport Reiches Capital Management, LLC69,075$513.2K
CAPROCK Group, Inc.10,944$81.3K
Lindbrook Capital, LLC1,416$10.5K